NEW AND EMERGING THERAPIES FOR THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
From Theory to Practice: Clinical Reasoning Series in Ambulatory Care Pharmacy
Saturday, October 20, 2012
8:30 a.m.–4:30 p.m.
ACCP 2012 Annual Meeting * October 21-24, 2012 * Hollywood, Florida
About From Theory to Practice: Clinical Reasoning Series in Ambulatory Care Pharmacy
From Theory to Practice: Clinical Reasoning Series in Ambulatory Care Pharmacy is one component of the professional development program developed by ACCP and approved by the Board of Pharmacy Specialties (BPS) for the recertification of the Board Certified Ambulatory Care Pharmacist (BCACP).
This live education series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It provides participants with active learning exercises designed to advance their skills and abilities to critically evaluate scientific evidence and clinical trials and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.
More information on the BCACP recertification professional development program is available at www.accp.com/careers/boardbcacp.aspx.
“New and Emerging Therapies for the Management of Type 2 Diabetes Mellitus” will provide an overview of new and emerging therapies for the management of patients with type 2 diabetes mellitus and discuss strategies that help inform individual patient care and formulary decisions. Sessions will address management guidelines, medication safety, formulary and pharmacoeconomic considerations, and pharmacist services.
Continuing Pharmacy Education Credit
Clinical pharmacists caring for patients with type 2 diabetes mellitus and BCACPs seeking recertification credit by continuing education
The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This is an application-based activity; Activity Number: 0217-0000-12-088-L01-P.
To earn continuing pharmacy education credit and to receive your continuing pharmacy education statement of credit for this activity, participants must attend all 6.0 contact hours of programming and complete the associated evaluation at www.accp.com/ce. Partial credit is not available for this activity.
BCACP Recertification Credit
To be eligible for 6.0 CPE hours of recertification credit, BCACPs must attend all 6.0 contact hours of live programming and successfully complete a Web-based posttest by November 30, 2012. Partial credit is not available for this activity.
- Provide an overview of new and emerging antidiabetic agents.
- Discuss the role of new agents and management strategies to optimize cost-effective patient care and minimize adverse drug events.
- Identify quality metrics for pharmacist services providing care to patients with type 2 diabetes mellitus.
||The Science of Diabetes Medications: Therapeutic Implications
||New and Emerging Antidiabetic Agents—Scientific and Clinical Evidence
||Management Guidelines—Integrating New Therapeutic Strategies
||Diabetes Medication Safety: Clinical Considerations and Impact on Health Care
||Formulary and Pharmacoeconomic Considerations
||Pharmacist Services—Patient Outcomes and Best Practices
Learning objectives for each of the sessions are available at www.accp.com/meetings/am12/.
||Amie D. McCord Brooks, Pharm.D., BCPS
Division of Pharmacy Practice
Saint Louis College of Pharmacy
Clinical Pharmacist in Primary Care
Saint Louis County Department of Health
St. Louis, Missouri
||Krystal L. Edwards, Pharm.D., BCPS
Texas Tech School of Pharmacy
||Laura Shane-McWhorter, PharmD., BCPS, BC-ADM, CDE, FASCP, FAADE
Department of Pharmacotherapy
University of Utah
College of Pharmacy
Salt Lake City, Utah
Julie Bartell, Pharm.D., BCACP, CACP
Pharmacotherapist, Residency Director
Brian K. Irons, Pharm.D., FCCP, BCACP, BCPS, BC-ADM
Associate Professor of Pharmacy Practice
Division Head-Ambulatory Care
Texas Tech University Health Sciences Center
Michael P. Kane, Pharm.D., FCCP, BCPS, BCACP
Albany College of Pharmacy and Health Sciences
Albany, New York
Registration fee includes syllabus, CPE credit, and access to the BCACP recertification posttest.
Full information on the agenda, learning objectives, faculty, and registration is available at www.accp.com/meetings/am12/.
No commercial support has been received for this activity.